StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jefferies Remains Sidelined on Thermo Fisher Scientific (TMO) Following Announced Acquisition of PTHN
May 16, 2017 7:25 AM
Jefferies reiterated a Hold rating and $175.00 price target on Thermo Fisher Scientific (NYSE: TMO) following the company's announced move ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Mergers and Acquisitions
Next Articles
Glenview Capital's 13F Shows New Stakes in Hain Celestial (HAIN), Shire (SHPG), T-Mobile (TMUS) (More...)
May 15, 2017 5:39 PM
Pre-Open Movers 05/15: (PTHN) (CYRN) (ALNY) Higher; (IONS) (SSYS) (TSLA) Lower (more...)
May 15, 2017 9:31 AM
Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
May 15, 2017 7:26 AM
Thermo Fisher Scientific (TMO) to Acquire Patheon (PTHN) for $7.2B
May 15, 2017 7:02 AM
Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO)
May 15, 2017 7:01 AM
Thermo Fisher Scientific (TMO) Said in Talks to Buy Patheon (PTHN) - Bloomberg
May 15, 2017 6:22 AM
Thermo Fisher in talks to buy Patheon: Bloomberg
May 15, 2017 12:03 AM
Tepper's Appaloosa 13F Shows New Stake in Bank of America (BAC), Increase in GM (GM), Arcelor Mittal (MT), Southwest Airlines (LUV), (More...)
May 12, 2017 4:12 PM